View in EDS HTML Full Text PDF Full Text

BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.

Saved in:
Bibliographic Details
Title: BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
Authors: Cohen M; Service de Neurologie, CRCSEP, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France., Mondot L; Service de Radiologie, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France., Bucciarelli F; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France., Pignolet B; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France., Laplaud DA; CRTI-INSERM U1064, CIC 1413, Service de Neurologie, CHU Nantes, Nantes, France., Wiertlewski S; CRTI-INSERM U1064, CIC 1413, Service de Neurologie, CHU Nantes, Nantes, France., Brochet B; Service de Neurologie, CRC SEP, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France., Ruet A; Service de Neurologie, CRC SEP, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France., Defer G; Service de Neurologie, CHU de Caen, Avenue de la Côte de Nacre, Caen, France., Derache N; Service de Neurologie, CHU de Caen, Avenue de la Côte de Nacre, Caen, France., Vermersch P; Univ. Lille, INSERM U1172, CHU Lille, FHU Imminent, Lille, France., Zephir H; Univ. Lille, INSERM U1172, CHU Lille, FHU Imminent, Lille, France., Debouverie M; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, Nancy, France., Mathey G; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, Nancy, France., Berger E; Service de Neurologie, CHU de Besançon, Besançon, France., Cappé C; Centre d'investigation clinique, CHU de Besançon, Besançon, France., Labauge P; CHU de Montpellier, MS Unit, Montpellier, France., Carra C; CHU de Montpellier, MS Unit, Montpellier, France., De Seze J; Clinical Investigation Center, Department of Neurology, CHU de Strasbourg, INSERM 1434, Strasbourg, France., Bigaut K; Clinical Investigation Center, Department of Neurology, CHU de Strasbourg, INSERM 1434, Strasbourg, France., Brassat D; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France., Lebrun-Frenay C; Service de Neurologie, CRCSEP, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Sep; Vol. 27 (10), pp. 1556-1563. Date of Electronic Publication: 2020 Oct 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-0970
DOI:10.1177/1352458520969145